share_log

Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Drops By 99.5%

Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Drops By 99.5%

Q BioMed Inc.(OTCMKTS: QBIO)的空头利率下降了99.5%
kopsource ·  2022/07/30 04:11

Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 100 shares, a drop of 99.5% from the June 30th total of 19,200 shares. Based on an average daily trading volume, of 844,800 shares, the short-interest ratio is currently 0.0 days.

Q BioMed Inc.(场外交易股票代码:QBIO — 获取评级)是7月份空头利率大幅下降的受益者。截至7月15日,空头利息共计100股,较6月30日的19,200股下降了99.5%。根据844,800股的平均每日交易量,空头利率目前为0.0天。

Q BioMed Price Performance

Q BioMed价格表现

Shares of QBIO traded down $0.01 during mid-day trading on Friday, hitting $0.17. 453,350 shares of the company's stock were exchanged, compared to its average volume of 234,883. The company has a market cap of $7.05 million, a PE ratio of -0.55 and a beta of 1.74. Q BioMed has a 52 week low of $0.04 and a 52 week high of $0.90. The company has a 50-day simple moving average of $0.08 and a 200 day simple moving average of $0.22.

QBIO的股票在周五午盘交易中下跌0.01美元,至0.17美元。该公司的股票交易量为453,350股,而平均交易量为234,883股。该公司的市值为705万美元,市盈率为-0.55,贝塔值为1.74。Q BioMed的52周低点为0.04美元,52周高点为0.90美元。该公司的50天简单移动平均线为0.08美元,200天简单移动平均线为0.22美元。

Get
得到
Q BioMed
Q BioMed
alerts:
警报:

About Q BioMed

关于 Q BioMed

(Get Rating)

(获取评级)

Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.
Q BioMed Inc是一家生物医学加速和开发公司,专注于向生命科学和医疗保健公司许可、收购和提供资源。该公司提供氯化锶SR89和Metastron,这是一种用于治疗转移性骨癌疼痛的放射性药物疗法。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
  • The One Question You Have to Ask Before Investing in INTC Stock
  • Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
  • Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
  • Why Apple Shares May Have Room to Move Higher After Earnings
  • Windfall Profits Have Exxon Mobil On Track For New Highs
  • 免费获取 StockNews.com 关于 Q BioMed(QBIO)的研究报告
  • 在投资INTC股票之前你必须问的一个问题
  • Home Depot:一只漂亮的无聊股票,可以驾驭熊市
  • CRISPR Therapeutics 会成为躲在众目之下的登月者吗?
  • 为什么苹果股价在财报后可能有上涨的空间
  • 意外利润使埃克森美孚有望创下新高

Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.

接收Q BioMed Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收关于Q BioMed及相关公司最新新闻的简明每日摘要和分析师的评级。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发